| Title |
|
|
|
Effect of primary tumor location on second-or later-line treatment outcomes in patients with RAS wild-type metastatic colorectal cancer and all treatment lines in patients with RAS mutations in four randomized panitumumab studies
| |
| Author |
|
|
|
| |
| Abstract |
|
|
| | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
Clinical colorectal cancer | |
| Publication |
|
|
|
2018
| |
| ISSN |
|
|
|
1533-0028
| |
| Volume/pages |
|
|
|
17:3(2018), p. 170-178
| |
| ISI |
|
|
|
000442669400019
| |
| Pubmed ID |
|
|
|
29627309
| |
| Full text (Publisher's DOI) |
|
|
| | |
| Full text (open access) |
|
|
| | |
|